Skip to content

Tina-quant CReactive Protein IV 07876432190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04015630946853), received between Feb 28, 2023 and Feb 19, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Non Reproducible Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Non Reproducible Results2
  • Incorrect Measurement1
  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 19, 2026Non Reproducible Results

    THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH TINA-QUANT C-REACTIVE PROTEIN I ON A COBAS C 111 ANALYZER. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE INITIALLY RESULTED IN A CRP VALUE OF 335.6 MG/L. THE REAGENT PACK WAS NEARLY DEPLETED AT THE TIME OF MEASUREMENT. A NEW REAGENT PACK WAS LOADED AND THE SAMPLE WAS REPEATED TWICE, RESULTING IN CRP VALUES OF 28.14 MG/L AND 28.29 MG/L.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24388222 ↗
  • MalfunctionSep 18, 2023Incorrect Measurement; Non Reproducible Results; Incorrect Measurement; Non Reproducible Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE CRPL4 C-REACTIVE PROTEIN GEN.4 RESULTS FOR 1 PATIENT SAMPLE ON A COBAS C 111 ANALYZER. ON (B)(6) 2023, THE INITIAL CRPL4 RESULT WAS 52 MG/DL. ON (B)(6) 2023, THE PATIENT PRESENTED BACK AT THE EMERGENCY ROOM WITH ABDOMINAL PAIN AND THIS PROMPTED THE CUSTOMER TO REPEAT THE ORIGINAL SAMPLE. THE SAMPLE WAS REPEATED THREE TIMES AND THE RESULTS WERE 0.67 MG/DL, 58 MG/DL, AND 133 MG/DL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17764674 ↗
  • MalfunctionFeb 28, 2023Low Test Results; Low Test Results

    THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT TESTED WITH CRPL4 C-REACTIVE PROTEIN GEN.4 ON A COBAS C 111 ((B)(4)). NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE INITIALLY RESULTED IN A CRP VALUE OF 0.71 MG/L. THE SAMPLE WAS REPEATED TWICE, RESULTING IN VALUES OF 75.85 MG/L AND 78.31 MG/L. THE 75.85 MG/L VALUE WAS REPORTED OUTSIDE OF THE LABORATORY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16456974 ↗

Other SYSTEM, TEST, C-REACTIVE PROTEIN devices

All SYSTEM, TEST, C-REACTIVE PROTEIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page